Vaccine Updates and Recommendations
April 24, 2021
Watch the video below for guidance on COVID-19 vaccines including efficacy, safety, potential risks and side effects for people living with Crohn's or colitis. Experts highlight research findings from studies investigating the impact of IBD medications and time delay between vaccine doses on COVID-19 vaccine efficacy and safety. The role of vaccines in developing antibodies and immunity to COVID-19, with special considerations for people with IBD, are also discussed.
Dr. Anne Pham-Huy (MD, FRCPC) Assistant Professor, Department of Pediatrics, University of Ottawa, Physician Lead, Primary Immunodeficiency Clinic and Pediatric Infectious Diseases Consultant, Program Director of the Pediatric Infectious Diseases Training Program, Children’s Hospital of Eastern Ontario (CHEO), Chair of Immunize Canada
Dr. Charlie W Lees (PhD, FRCP) Professor , Institute of Genetics & Molecular Medicine, University of Edinburgh, Chair of Gastroenterology & Consultant Gastroenterologist,Western General Hospital, UKRI Future Leaders Fellow
Dr. Gilaad Kaplan (MD, MPH, FRCPC), Professor of Medicine, Gastroenterologist and Epidemiologist, Departments of Medicine and Community Health Sciences, University of Calgary, Past Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada l Twitter: @gilkaplan
Dr. Eric Benchimol (MD, PhD, FRCPC), Professor, Pediatric Gastroenterologist, Department of Paediatrics, The Hospital for Sick Children (SickKids) and University of Toronto, Division of Gastroenterology, Hepatology and Nutrition, SickKids, NASPGHAN Canadian Councilor, Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada | Twitter: @ericbenchimol
Want to help boost our research initiatives?
Text CURE to 20222 to donate $25 to Crohn’s and Colitis Canada’s critical research projects.